/WRBY
WRBY Stock - Warby Parker Inc.
Healthcare|Medical - Instruments & SuppliesNYSE
$29.09+9.46%
+$2.52 (+9.46%) • Jan 13
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.90
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).65
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.38
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+7.3%upside
Target: $31.21
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for WRBY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$28.80 – $29.38
TARGET (TP)$31.20
STOP LOSS$26.76
RISK/REWARD1:0.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.06
52W High$31.00
52W Low$13.63
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $771.32M | $669.76M | $598.11M | $540.80M | $393.72M |
| Gross Profit | $426.83M | $365.22M | $341.06M | $317.75M | $231.94M |
| Gross Margin | 55.3% | 54.5% | 57.0% | 58.8% | 58.9% |
| Operating Income | $-30,112,000 | $-71,996,000 | $-111,203,000 | $-143,661,000 | $-55,632,000 |
| Net Income | $-20,390,000 | $-63,197,000 | $-110,393,000 | $-144,271,000 | $-55,919,000 |
| Net Margin | -2.6% | -9.4% | -18.5% | -26.7% | -14.2% |
| EPS | $-0.17 | $-0.54 | $-0.96 | $-1.39 | $-0.50 |
Company Overview
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
WRBYBeat Rate
47%
Last 17 quarters
Avg Surprise
-67.7%
EPS vs Estimate
Beats / Misses
8/6
3 met exactly
Latest EPS
$0.11
Q4 2025
EPS Surprise History
Q1 24
-232.2%
$-0.01vs$-0.00
Q2 24
+14.3%
$0.08vs$0.07
Q3 24
+20.0%
$0.06vs$0.05
Q4 24
0.0%
$0.05vs$0.05
Q1 25
-66.7%
$0.01vs$0.03
Q2 25
0.0%
$0.12vs$0.12
Q3 25
0.0%
$0.08vs$0.08
Q4 25
+22.2%
$0.11vs$0.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.05 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.09 | $0.11 | +22.2% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.08 | $0.08 | 0.0% | = MET |
Q2 2025 | May 8, 2025 | $0.12 | $0.12 | 0.0% | = MET |
Q1 2025 | Feb 27, 2025 | $0.03 | $0.01 | -66.7% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $0.05 | $0.05 | 0.0% | = MET |
Q3 2024 | Aug 8, 2024 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $0.07 | $0.08 | +14.3% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $-0.00 | $-0.01 | -232.2% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $0.01 | $0.01 | +4.6% | ✓ BEAT |
Q3 2023 | Aug 9, 2023 | $0.02 | $0.04 | +73.9% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $-0.02 | $-0.17 | -663.4% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $0.01 | $0.01 | -32.6% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-0.01 | $-0.01 | -52.7% | ✗ MISS |
Q2 2022 | May 16, 2022 | $-0.06 | $-0.30 | -383.8% | ✗ MISS |
Q1 2022 | Mar 17, 2022 | $-0.10 | $-0.08 | +20.0% | ✓ BEAT |
Q4 2021 | Nov 12, 2021 | $-0.63 | $0.03 | +104.8% | ✓ BEAT |
Q3 2021 | Sep 29, 2021 | — | $0.27 | — | — |
Latest News
Loading news...
Frequently Asked Questions about WRBY
What is WRBY's current stock price?
Warby Parker Inc. (WRBY) is currently trading at $29.09 per share. The stock has moved +9.46% today.
What is the analyst price target for WRBY?
The average analyst price target for WRBY is $31.20, based on 1 analyst.
What sector is Warby Parker Inc. in?
Warby Parker Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NYSE exchange.
What is WRBY's market cap?
Warby Parker Inc. has a market capitalization of $3.55 billion, making it a mid-cap company.
Does WRBY pay dividends?
No, Warby Parker Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBEAM
Beam Therapeutics Inc.
$34.55
Mkt Cap: $3.5B
BHC
Bausch Health Companies Inc.
$7.50
Mkt Cap: $2.8B
CON
Concentra Group Holdings Parent, Inc.
$20.28
Mkt Cap: $2.6B
HAE
Haemonetics Corporation
$78.82
Mkt Cap: $3.8B
ICUI
ICU Medical, Inc.
$148.28
Mkt Cap: $3.7B
ITGR
Integer Holdings Corporation
$82.74
Mkt Cap: $2.9B
LMAT
LeMaitre Vascular, Inc.
$83.34
Mkt Cap: $1.9B
PINC
Premier, Inc.
$28.26
Mkt Cap: $2.3B
QDEL
QuidelOrtho Corporation
$33.30
Mkt Cap: $2.3B
XRAY
DENTSPLY SIRONA Inc.
$12.13
Mkt Cap: $2.4B
Explore stocks similar to WRBY for comparison